Bicycle Therapeutics plc (NASDAQ: BCYC) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT BICYCLE THERAPEUTICS PLC

Bicycle Therapeutics plc (NASDAQ: BCYC)
Listen to this Section


$4.11
-0.1650 ( -3.86% ) 282.3K

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.

Market Data


Open $4.11
Previous Close $4.27
Volume 282.3K
Market Cap $293.21M
Day Range $4.10 - $4.41
52 Week Range $4.10 - $9.36
Shares Outstanding 69.81M
Change % -3.86%
Net Change ▼ -0.1650
Insider Ownership -0.01%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2019
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -2,025,887.00

Date Type Amount Purchased Purchaser
2024-01-04 Sale -6000.00 Jordan Veronica GH
2024-01-04 Sale -12000.00 Legault Pierre
2024-01-04 Sale -28000.00 Keen Nicholas
2024-01-04 Sale -6000.00 Bourque Janice
2024-01-04 Sale -6000.00 Gutierrez-Ramos Jose-Carlos
2023-10-05 Sale -442.00 Milnes Alistair
2023-10-05 Sale -54.00 Thompson Travis Alvin
2023-10-05 Sale -272.00 Keen Nicholas
2023-10-05 Sale -442.00 Crockett Nigel
2023-10-05 Sale -1470.00 Lee Kevin

SEC Filings


Form Type Description Pages Date
8-k 8K-related 14 Oct 30, 2025
10-q Quarterly Reports 77 Oct 30, 2025
4 Insider transactions 1 Oct 06, 2025
4 Insider transactions 1 Oct 06, 2025
4 Insider transactions 1 Oct 06, 2025
4 Insider transactions 1 Oct 06, 2025
4 Insider transactions 1 Oct 06, 2025
4 Insider transactions 1 Oct 06, 2025
4 Insider transactions 1 Oct 06, 2025
4 Insider transactions 1 Sep 10, 2025

Latest News


× Before browsing our site, please accept our cookies policy